Wrap Text
Issue of Shares and Cleansing Statement and amended Appendix 3B
Tawana Resources NL
(Incorporated in Australia)
(Registration number ACN 085 166 721)
Share code on the JSE Limited: TAW
JSE ISIN: AU0000TAWDA9
Share code on the Australian Securities Exchange Limited: TAW
ASX ISIN: AU000000TAW7
(“the Company” or “Tawana”)
Issue of Shares, Cleansing Statement and amended Appendix 3B
Tawana Resources NL (“Tawana” or the “Company”) advises that it has issued
4,000,000 fully paid ordinary shares on the exercise of options as per the Appendix
3B lodged today.
With reference to the shares issued, in accordance with section 708A(6) of the
Corporations Act 2001 (Cth) (Corporations Act), the Company gives notice under
paragraph 708A(5)(e) that:
1. The shares were issued without disclosure to investors under Part 6D.2 of the
Corporations Act;
2. As at the date of this notice:
a. The Company has complied with the provisions of Chapter 2M of the
Corporations Act as it applies to the Company;
b. The Company has complied with section 674 of the Corporations Act; and
c. There is no excluded information within the meaning of sections 708A(7)
and 708A(8) of the Corporations Act which is required to be disclosed under
section 708A(6)(e) of the Corporations Act.
For further information, please contact:
Claire O’Brien
Company Secretary
Tawana Resources NL
2 July 2018
Sponsor
PricewaterhouseCoopers Corporate Finance (Pty) Ltd
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity
TAWANA RESOURCES NL
ABN
69 085 166 721
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued or Fully Paid Ordinary Shares
to be issued
2 Number of +securities issued 4,000,000 Fully Paid Ordinary Shares
or to be issued (if known) or
maximum number which may
be issued
3 Principal terms of the Fully Paid Ordinary Shares
+securities (eg, if options,
exercise price and expiry date;
if partly paid +securities, the
amount outstanding and due
dates for payment; if
+convertible securities, the
conversion price and dates for
conversion)
4 Do the +securities rank equally in
all respects from the date of Yes
allotment with an existing +class
of quoted +securities?
If the additional securities do not
rank equally, please state:
- the date from which they do
- the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
- the extent to which they do
not rank equally, other than
in relation to the next
dividend, distribution or
interest payment
5 Issue price or consideration 1,000,000 @ $0.06 per share
1,000,000 @ $0.16 per share
500,000 @ $0.18 per share
1,500,000 @ $0.20 per share
6 Purpose of the issue Exercise of Employee Incentive options and
(If issued as consideration for the Director options
acquisition of assets, clearly
identify those assets)
6a Is the entity an +eligible entity No
that has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i
6b The date the security holder N/A
resolution under rule 7.1A was
passed
6c Number of +securities issued N/A
without security holder approval
under rule 7.1
6d Number of +securities issued N/A
with security holder approval
under rule 7.1A
6e Number of +securities issued N/A
with security holder approval
under rule 7.3, or another
specific security holder approval
(specify date of meeting)
6f Number of securities issued N/A
under an exception in rule 7.2
6g If securities issued under rule N/A
7.1A, was issue price at least 75%
of 15 day VWAP as calculated
under rule 7.1A.3? Include the
issue date and both values.
Include the source of the VWAP
calculation.
6h If securities were issued under N/A
rule 7.1A for non-cash
consideration, state date on
which valuation of consideration
was released to ASX Market
Announcements
6i Calculate the entity’s remaining 7.1 – 83,413,636
issue capacity under rule 7.1 and 7.1A – N/A
rule 7.1A – complete Annexure 1
and release to ASX Market
Announcements
7 Dates of entering +securities into 29 June 2018
uncertificated holdings or
despatch of certificates
Number +Class
8 Number and +class of all 561,988,335 Ordinary Fully Paid
+securities quoted on ASX Shares
(including the securities in
section 2 if applicable)
Number +Class
9 Number and +class of all 3,000,000 Class H Incentive Options
+securities not quoted on ASX ($0.06, 30 June 2019)
(including the securities in 1,250,000 Class J Incentive Options
section 2 if applicable) ($0.13, 7 January 2020)
500,000 Class N Incentive Options
($0.23, 27 March 2020)
3,000,000 Class O Corporate Advisor Options
($0.20, 12 April 2020)
3,000,000 Class P Corporate Advisor Options
($0.25, 12 April 2020)
3,000,000 Class Q Corporate Advisor Options
($0.30, 12 April 2020)
6,346,940 Advisor Options
($0. 30625, 19 July 2020)
500,000 Class O Incentive Options, ($0.22, and
$0.24, 21 August 2020)
1,000,000 Director Options
($0.20, 20 December 2020)
1,000,000 Class S Incentive Options
($0.50, 6 April 2021)
10 Dividend policy (in the case of a Unchanged
trust, distribution policy) on the
increased capital (interests)
Part 2 - Bonus issue or pro rata issue
11 Is security holder approval N/A
required?
12 Is the issue renounceable or non- N/A
renounceable?
13 Ratio in which the +securities will N/A
be offered
14 +Class of +securities to which the N/A
offer relates
15 +Record date to determine N/A
entitlements
16 Will holdings on different N/A
registers (or subregisters) be
aggregated for calculating
entitlements?
17 Policy for deciding entitlements N/A
in relation to fractions
18 Names of countries in which the N/A
entity has +security holders who
will not be sent new issue
documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt of N/A
acceptances or renunciations
20 Names of any underwriters N/A
21 Amount of any underwriting fee N/A
or commission
22 Names of any brokers to the issue N/A
23 Fee or commission payable to the N/A
broker to the issue
24 Amount of any handling fee N/A
payable to brokers who lodge
acceptances or renunciations on
behalf of +security holders
25 If the issue is contingent on N/A
+security holders’ approval, the
date of the meeting
26 Date entitlement and acceptance N/A
form and prospectus or Product
Disclosure Statement will be sent
to persons entitled
27 If the entity has issued options, N/A
and the terms entitle option
holders to participate on exercise,
the date on which notices will be
sent to option holders
28 Date rights trading will begin (if N/A
applicable)
29 Date rights trading will end (if N/A
applicable)
30 How do +security holders sell N/A
their entitlements in full through
a broker?
31 How do +security holders sell part N/A
of their entitlements through a
broker and accept for the
balance?
32 How do +security holders dispose N/A
of their entitlements (except by
sale through a broker)?
33 +Issue date N/A
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities
(tick one)
(a) ? Securities described in Part 1
(b) All other securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35 If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of securities for which
+quotation is sought
39 Class of +securities for which
quotation is sought
40 Do the +securities rank equally in
all respects from the date of
allotment with an existing +class
of quoted +securities?
If the additional securities do not
rank equally, please state:
- the date from which they do
- the extent to which they
participate for the next
dividend, (in the case of a trust,
distribution) or interest
payment
- the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest
payment
41 Reason for request for quotation
now
Example: In the case of restricted securities, end
of restriction period
(if issued upon conversion of
another security, clearly identify
that other security)
Number +Class
42 Number and +class of all
+securities quoted on ASX
(including the securities in clause
38)
Quotation agreement
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX
may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
- The issue of the +securities to be quoted complies with the law and is
not for an illegal purpose.
- There is no reason why those +securities should not be granted
+quotation.
- An offer of the +securities for sale within 12 months after their issue will
not require disclosure under section 707(3) or section 1012C(6) of the
Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able
to give this warranty
- Section 724 or section 1016E of the Corporations Act does not apply to
any applications received by us in relation to any +securities to be
quoted and that no-one has any right to return any +securities to be
quoted under sections 737, 738 or 1016F of the Corporations Act at the
time that we request that the +securities be quoted.
- If we are a trust, we warrant that no person has the right to return the
+securities to be quoted under section 1019B of the Corporations Act at
the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any
claim, action or expense arising from or connected with any breach of the
warranties in this agreement.
4 We give ASX the information and documents required by this form. If any
information or document not available now, will give it to ASX before
+quotation of the +securities begins. We acknowledge that ASX is relying on
the information and documents. We warrant that they are (will be) true and
complete.
Sign here: ................... ........................ …. Date: 29 June 2018
(Company secretary)
Print name: Claire O’Brien
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A
for +eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid ordinary 442,117,700
securities on issue 12 months before date
of issue or agreement to issue
Add the following: 3,405,000 (exercise of options on 1 November
• Number of fully paid ordinary 2017)
securities issued in that 12 month 1,000,000 (exercise of options on 20 November
period under an exception in rule 7.2
2017)
• Number of fully paid ordinary
14,285,714 (ratified at shareholder meeting
securities issued in that 12 month
period with shareholder approval dated 12 December 2017)
• Number of partly paid ordinary 42,857,143 (ratified at shareholder meeting
securities that became fully paid in dated 12 December 2017)
that 12 month period
696,530 (exercise of options on 11 January
Note:
• Include only ordinary securities here – 2018)
other classes of equity securities 326,530 (exercise of options on 10 April 2018)
cannot be added
250,000 (exercise of options on 10 May 2018)
• Include here (if applicable) the
securities the subject of the Appendix 2,500,000 (exercise of options on 18 May 2018)
3B to which this form is annexed 1,000,000 (exercise of options on 18 May 2018)
• It may be useful to set out issues of
securities on different dates as 47,930,488 shares (ratified at shareholder
separate line items meeting 29 May 2018)
850,000 shares (ratified at shareholder meeting
29 May 2018)
4,000,000 (exercise of options on 29 June 2018)
Subtract the number of fully paid ordinary -
securities cancelled during that 12 month
period
“A” 561,219,105
Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15 84,182,866
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of equity securities issued
615,384 Fully Paid Ordinary Shares
or agreed to be issued in that 12 month
(Issued
period not counting those issued:
06/11/2017)
• Under an exception in rule 7.2
153,846 Fully Paid Ordinary Shares
• Under rule 7.1A (Issued
• With security holder approval under
21/05/2018)
rule 7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable ) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as
separate line items
“C” 769,230
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15 84,182,866
Note: number must be same as shown in
Step 2
Subtract “C” 769,230
Note: number must be same as shown in
Step 3
Total [“A” x 0.15] – “C” 83,413,636
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A” Not Applicable
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of “A”
“D” 0.10
Note: this value cannot be changed
Multiply “A” by 0.10
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of equity securities issued or
agreed to be issued in that 12 month period
under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
“E”
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
Subtract “E”
Note: number must be same as shown in
Step 3
Total [“A” x 0.10] – “E” Note: this is the remaining placement
capacity under rule 7.1A
Date: 02/07/2018 09:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
